🇺🇸 FDA
Patent

US 12319929

Compositions and methods for the treatment of Parkinson's disease

granted A61KA61K38/51A61K48/005

Quick answer

US patent 12319929 (Compositions and methods for the treatment of Parkinson's disease) held by VOYAGER THERAPEUTICS, INC. expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
VOYAGER THERAPEUTICS, INC.
Grant date
Tue Jun 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K38/51, A61K48/005, A61P, A61P25/16